Clinical trial Recruiting at 1 site Interventional

Connecting underrepresented populations to clinical trials at Ohio State University

Official title: The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) Project

Run by Ohio State University Comprehensive Cancer Center · NCT06314672 · Data updated 2026-11-12

This study is trying to find better ways to connect racial and ethnic minorities to cancer clinical trials at Ohio State University to help them participate more.

Quick facts

Study typeInterventional
SexAll
Enrollment208 (estimated)
SponsorOhio State University Comprehensive Cancer Center
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedAugust 22, 2023
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJune 9, 2026
Trial IDNCT06314672 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include racial and ethnic minorities residing in the Ohio State University Comprehensive Cancer Center catchment area.

Probably not a fit

Patients who are not part of racial or ethnic minority groups may not receive direct benefits from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to improve the referral and enrollment of racial and ethnic minorities in clinical trials for cancer treatment and prevention. It involves a multi-phase approach, starting with a baseline assessment of current referral patterns and barriers to participation. Following this, a multi-level intervention will be implemented across ten counties to enhance accrual to clinical trials. The effectiveness of these interventions will be evaluated to determine their impact on increasing minority participation in clinical trials.

Why it matters

Potential benefit: If successful, this project could significantly increase access to clinical trials for underrepresented populations, leading to better cancer treatment outcomes.

How similar studies have gone: Other studies have shown success in increasing minority participation in clinical trials through targeted outreach and education efforts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Phase I: 9 counties in the OSUCCC catchment area
* Phase II: Patients, providers, and hospital systems/referral centers that directly addresses challenges identified in Phase I
* Phase II: The project will involve the OSUCCC, the OSU James Cancer Network sites and the Columbus and Dayton NCORP sites

Where it's running

  • Ohio State University Comprehensive Cancer Center
    Columbus, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: Electra D Paskett, PhD — Ohio State University Comprehensive Cancer Center
  • Study coordinator: The Ohio State Comprehensive Cancer Center
  • Email: OSUCCCClinicaltrials@osumc.edu
  • Phone: 800-293-5066

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.